<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph-family" /><meta name="keywords" content="Taxanes; Paclitaxel; Docetaxel; Cabazitaxel" /><meta name="IX" content="Taxanes; Paclitaxel; Docetaxel; Cabazitaxel" /><title>Taxanes: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="21850.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="21850.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=21850.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2075.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="4676.htm">8.1 Cytotoxic drugs</a> &gt; <a href="4758.htm">8.1.5 Other antineoplastic drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="201443.htm" title="Previous: TEMSIROLIMUS">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="214621.htm" title="Next: CABAZITAXEL">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a311007.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cabazitaxel</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Antineoplastic Agents 10:00</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a396031.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Docetaxel</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Antineoplastic Agents 10:00</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a398035.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Paclitaxel</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Antineoplastic Agents 10:00</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/14634-b.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Docetaxel</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: D &gt; Interactions of Docetaxel</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/2453-y.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Paclitaxel</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: P &gt; Interactions of Paclitaxel</p></div></li></ul><ul><li><h3>British National Formulary (8)</h3></li><li><a href="214621.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">CABAZITAXEL</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Taxanes</p></div></li><li><a href="39251.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">DOCETAXEL</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Taxanes</p></div></li><li><a href="213604.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Docetaxel</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.5 Other antineoplastic drugs &gt; Taxanes &gt; DOCETAXEL</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22taxanes%22%22paclitaxel%22%22docetaxel%22%22cabazitaxel%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (8)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0589.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Docetaxel</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; D</p></div></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1251.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Paclitaxel</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; P</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a500003.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Docetaxel</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; D</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a593005.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Paclitaxel</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; P</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0004s0282.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Docetaxel</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; D</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0015s0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Paclitaxel</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; P</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/25232-w.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cabazitaxel</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antineoplastics &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/14634-b.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Docetaxel</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antineoplastics &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/2453-y.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Paclitaxel</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antineoplastics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/10493.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cabazitaxel</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; C &gt; CA</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/03397.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Docetaxel</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; D &gt; DO</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/06982.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Paclitaxel</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; P &gt; PA</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E56E3E0R0D1808.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Cabazitaxel</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E10E3E0R0D1580.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Docetaxel</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; D</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E14E3E0R0D647.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Paclitaxel</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; P</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22taxanes%22%22paclitaxel%22%22docetaxel%22%22cabazitaxel%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_21850">Taxanes</h1><?highlighter on?><div id="pC" class="jN"><div><div id="_1199889402152"><p><b><span>Paclitaxel</span> </b> is a member of the taxane group of drugs. It is given
by <i>intravenous infusion</i>. <span>Paclitaxel</span> given with <span>carboplatin</span> or <span>cisplatin</span> is used for the treatment of ovarian cancer (see <a title="target-block: paclitaxel for ovarian cancer nice guidance" href="67743.htm#_67743.4">NICE guidance</a>); the combination is also considered appropriate for women whose
ovarian cancer is initially considered inoperable. <span>Paclitaxel</span> is also licensed for the secondary treatment of metastatic breast
cancer. There is limited evidence to support its use in non-small
cell lung cancer. <span id="_21850.2">Routine premedication with a corticosteroid, an antihistamine
and a histamine H<sub>2</sub>-receptor antagonist is recommended to
prevent severe hypersensitivity reactions; hypersensitivity reactions may occur rarely despite premedication, although more commonly only bradycardia or asymptomatic hypotension
occur</span>.</p><p>Other side-effects of <span>paclitaxel</span> include
myelosuppression, peripheral neuropathy, and cardiac conduction defects
with arrhythmias (which are nearly always asymptomatic). It also causes
alopecia and muscle pain; nausea and vomiting is mild to moderate.</p></div><div id="_1199889434497"><p><b>Docetaxel</b> is licensed for use in locally advanced or metastatic breast cancer
and non-small cell lung cancer resistant to other cytotoxic drugs
or for initial chemotherapy in combination with other cytotoxic drugs.
It is also licensed for hormone-resistant prostate cancer, for use
with other cytotoxic drugs for gastric adenocarcinoma and head and
neck cancer, and for adjuvant treatment of operable node-positive
and operable node-negative breast cancer. <span id="_21850.3">Its side-effects are similar to those of paclitaxel
but persistent fluid retention (commonly as leg oedema that worsens
during treatment) can be resistant to treatment; hypersensitivity
reactions also occur. Pretreatment with dexamethasone
by mouth is recommended for reducing fluid retention and hypersensitivity
reactions.</span></p><p>For the role of taxanes in the treatment of breast cancer, see <a title="BNF:sub-sub-section: Breast cancer" href="4821.htm#_4821">section 8.3.4.1</a>.</p><p>The <a title="target-block: NICE and Scottish Medicines Consortium" href="29404.htm#_200790"><i>Scottish Medicines
Consortium</i></a> has advised that docetaxel (<span class="cZ">Taxotere</span>®) in combination
with cisplatin and fluorouracil is accepted for restricted use within
NHS Scotland for the induction treatment of patients with unresectable
(May 2007) and resectable (June 2008) locally advanced squamous cell
carcinoma of the head and neck.</p></div><div id="_21850.4"></div><div class="cN"><h3 class="cBP">NICE guidance (paclitaxel, pegylated liposomal doxorubicin
and topotecan for second-line or subsequent treatment of advanced
ovarian cancer)</h3><p>See <a title="target-block: paclitaxel, doxorubicin, topotecan nice guidance" href="67743.htm#_67743.3">Platinum Compounds</a></p></div><div class="cN"><h2 class="cBR">NICE guidance</h2><h3 class="cBP">Docetaxel for the treatment of hormone-refractory
metastatic prostate cancer (June 2006)</h3><p>Docetaxel is an option for hormone-refractory metastatic prostate
cancer and a Karnofsky score of at least 60% [Karnofsky score is a
measure of the ability to perform ordinary tasks].</p></div><div id="_215604"><p><b>Cabazitaxel</b>, in combination
with prednisone or prednisolone, is licensed for the treatment of
hormone refractory metastatic prostate cancer in patients who have
previously been treated with a docetaxel-containing regimen. Routine
premedication with a corticosteroid, an antihistamine, and a histamine
H<sub>2</sub>-receptor antagonist is recommended to prevent severe
hypersensitivity reactions. Hypersensitivity reactions are common.</p><p>Other side-effects of cabazitaxel include weight changes, diarrhoea,
constipation, abdominal pain, dyspepsia, gastroesophageal reflux,
haemorrhoids, rectal haemorrhage, taste disturbance, dry mouth, chest
pain, atrial fibrillation, tachycardia, hypertension, hypotension,
flushing, oedema, dyspnoea, cough, peripheral neuropathy, paraesthesia,
hypoesthesia, anxiety, confusion, dizziness, headache, malaise, vertigo,
chills, hyperglycaemia, urinary retention, urinary incontinence, renal
disorders (fatal cases of renal failure reported), dehydration, electrolyte
disturbances, sciatica, arthralgia, muscle spasm, myalgia, increased
lacrimation, tinnitus, dry skin, erythema.</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_214621"><a href="214621.htm" title="CABAZITAXEL">CABAZITAXEL</a></li><li id="_39251"><a href="39251.htm" title="DOCETAXEL">DOCETAXEL</a></li><li id="_21851"><a href="21851.htm" title="PACLITAXEL">PACLITAXEL</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="201443.htm">Previous: TEMSIROLIMUS</a> | <a class="top" href="21850.htm#">Top</a> | <a accesskey="]" href="214621.htm">Next: CABAZITAXEL</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>